孕產婦心理健康市場－全球產業規模、佔有率、趨勢、機會和預測（按疾病適應症、療法、地區和競爭細分，2020-2030 年）

2024 年全球孕產婦心理健康市場規模達 58.3 億美元，預計到 2030 年將達到新的成長水平，年複合成長率為 9.23%。孕產婦心理健康，包括產後憂鬱、焦慮和創傷後壓力症候群等疾病，日益被視為公共衛生優先事項。這些心理健康問題可能在懷孕期間或產後出現，對母親和嬰兒都有嚴重影響，包括早產和發育問題。人們意識的提高、求助行為的常態化以及心理健康服務可近性的改善，促進了市場的成長。此外，醫療服務提供者和政策制定者正在實施更全面的篩檢和治療策略。行動健康應用程式、穿戴式監測設備和人工智慧分析等技術進步也在早期發現和個人化介入中發揮關鍵作用。全球出生率的上升，加上人們意識的增強和支持基礎設施的完善，預計將在未來幾年推動孕產婦心理健康市場的強勁成長。

關鍵市場促進因素

孕產婦心理健康障礙的高發生率正在推動全球孕產婦心理健康市場的發展

主要市場挑戰

恥辱與意識

主要市場趨勢

技術進步

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球孕產婦心理健康市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依疾病指徵（產後憂鬱症、心境惡劣症、妊娠及產後廣泛性焦慮症、妊娠及產後強迫症、分娩相關創傷後壓力症候群、其他）
  • 透過治療（人際心理治療、抗憂鬱藥物、認知行為療法等）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美孕產婦心理健康市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲孕產婦心理健康市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第8章：亞太地區孕產婦心理健康市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲孕產婦心理健康市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲孕產婦心理健康市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購
• 產品開發
• 最新動態

第 13 章：全球孕產婦心理健康市場：SWOT 分析

第 14 章：競爭格局

• Therapy Mama
• Canopie
• Pfizer Inc
• Viatris Inc.
• GlaxoSmithKline Inc.
• Alembic Pharmaceuticals Limited
• Mallinckrodt Inc.
• Sage Therapeutics, Inc.
• Bausch Health Companies Inc.
• Magellan Health, Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

The Global Maternal Mental Health Market was valued at USD 5.83 billion in 2024 and is projected to reach new growth levels by 2030, expanding at a CAGR of 9.23%. Maternal mental health, encompassing conditions such as postpartum depression, anxiety, and PTSD, is increasingly recognized as a public health priority. These mental health challenges can arise during pregnancy or the postpartum period and have serious implications for both mother and child, including premature birth and developmental issues. Rising awareness, the normalization of seeking help, and improved access to mental healthcare services are contributing to the market's growth. Additionally, healthcare providers and policy makers are implementing more comprehensive screening and treatment strategies. Technological advancements, including mobile health apps, wearable monitoring devices, and AI-powered analytics, are also playing a pivotal role in early detection and personalized intervention. The increasing global birth rate, coupled with heightened awareness and support infrastructure, is expected to fuel robust growth in the maternal mental health market over the coming years.

Key Market Drivers

High Prevalence of Maternal Mental Health Disorders is Driving Global Maternal Mental Health Market

The increasing recognition of the prevalence and impact of perinatal mental health disorders is a primary driver for the market. Conditions such as postpartum depression, general anxiety, and PTSD are now known to affect a substantial proportion of women during and after pregnancy. Studies indicate that up to one in seven women in the U.S. experience postpartum depression, with other regions reflecting similarly high rates. The COVID-19 pandemic further intensified maternal mental health concerns, with research from the University of Michigan highlighting that nearly one in three mothers during early 2020 experienced symptoms of depression. This growing awareness has encouraged greater demand for mental health services tailored specifically to the maternal population. Healthcare systems, non-profits, and governments are increasingly supporting maternal mental health programs, while tech firms and pharmaceutical companies are innovating around treatment and support tools, further driving market expansion.

Key Market Challenges

Stigma and Awareness

One of the major obstacles hindering market growth is the persistent stigma surrounding mental health during and after pregnancy. Many women feel pressured to conform to societal expectations that motherhood should be a purely joyful experience, leading to feelings of guilt or fear of judgment if they disclose emotional distress. As a result, many mothers delay or avoid seeking treatment altogether. Compounding this issue is the lack of consistent mental health screening in prenatal and postpartum care. To combat these barriers, efforts must focus on awareness campaigns, caregiver training, and integration of mental health checks into routine maternal care. Destigmatizing maternal mental health through education and supportive community platforms remains essential to unlocking further growth in the market.

Key Market Trends

Technological Advancements

Technology is playing a transformative role in the maternal mental health market. The rise of telehealth has made it easier for women to access care from the safety and privacy of their homes. Mobile apps designed for mood tracking, meditation, and personalized support are becoming more prevalent, offering scalable and accessible mental health solutions. Wearable technologies also support continuous monitoring of vital signs and stress indicators, enabling early detection of mental distress. Artificial Intelligence is being used to analyze behavioral and physiological data, helping predict mental health risks and guide timely interventions. Moreover, Virtual Reality is emerging as a therapeutic tool for treating postpartum anxiety and PTSD by offering immersive relaxation and exposure therapy experiences. Collectively, these technological developments are helping to reduce barriers to care, improve treatment personalization, and enhance patient engagement.

Key Market Players

• Therapy Mama
• Canopie
• Pfizer Inc
• Viatris Inc.
• GlaxoSmithKline Inc.
• Alembic Pharmaceuticals Limited
• Mallinckrodt Inc.
• Sage Therapeutics, Inc.
• Bausch Health Companies Inc.
• Magellan Health, Inc.

Report Scope:

In this report, the Global Maternal Mental Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Maternal Mental Health Market, By Disease Indication:

• Postpartum Depression
• Dysthymia
• Pregnancy and Postpartum General Anxiety
• Pregnancy and Postpartum OCD
• Birth-Related PTSD
• Others

Maternal Mental Health Market, By Therapy:

• Interpersonal Psychotherapy
• Antidepressants
• Cognitive Behavioral Therapy
• Others

Maternal Mental Health Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Maternal Mental Health Market.

Available Customizations:

Global Maternal Mental Health market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Maternal Mental Health Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others)
  • 5.2.2. By Therapy (Interpersonal Psychotherapy, Antidepressants, Cognitive Behavioral Therapy, others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Maternal Mental Health Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Disease Indication
  • 6.2.2. By Therapy
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Maternal Mental Health Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Disease Indication
      • 6.3.1.2.2. By Therapy
  • 6.3.2. Canada Maternal Mental Health Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Disease Indication
      • 6.3.2.2.2. By Therapy
  • 6.3.3. Mexico Maternal Mental Health Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Disease Indication
      • 6.3.3.2.2. By Therapy

7. Europe Maternal Mental Health Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Disease Indication
  • 7.2.2. By Therapy
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Maternal Mental Health Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Disease Indication
      • 7.3.1.2.2. By Therapy
  • 7.3.2. United Kingdom Maternal Mental Health Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Disease Indication
      • 7.3.2.2.2. By Therapy
  • 7.3.3. Italy Maternal Mental Health Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Disease Indication
      • 7.3.3.2.2. By Therapy
  • 7.3.4. France Maternal Mental Health Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Disease Indication
      • 7.3.4.2.2. By Therapy
  • 7.3.5. Spain Maternal Mental Health Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Disease Indication
      • 7.3.5.2.2. By Therapy

8. Asia-Pacific Maternal Mental Health Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Disease Indication
  • 8.2.2. By Therapy
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Maternal Mental Health Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Disease Indication
      • 8.3.1.2.2. By Therapy
  • 8.3.2. India Maternal Mental Health Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Disease Indication
      • 8.3.2.2.2. By Therapy
  • 8.3.3. Japan Maternal Mental Health Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Disease Indication
      • 8.3.3.2.2. By Therapy
  • 8.3.4. South Korea Maternal Mental Health Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Disease Indication
      • 8.3.4.2.2. By Therapy
  • 8.3.5. Australia Maternal Mental Health Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Disease Indication
      • 8.3.5.2.2. By Therapy

9. South America Maternal Mental Health Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Disease Indication
  • 9.2.2. By Therapy
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Maternal Mental Health Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Disease Indication
      • 9.3.1.2.2. By Therapy
  • 9.3.2. Argentina Maternal Mental Health Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Disease Indication
      • 9.3.2.2.2. By Therapy
  • 9.3.3. Colombia Maternal Mental Health Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Disease Indication
      • 9.3.3.2.2. By Therapy

10. Middle East and Africa Maternal Mental Health Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Disease Indication
  • 10.2.2. By Therapy
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Maternal Mental Health Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Disease Indication
      • 10.3.1.2.2. By Therapy
  • 10.3.2. Saudi Arabia Maternal Mental Health Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Disease Indication
      • 10.3.2.2.2. By Therapy
  • 10.3.3. UAE Maternal Mental Health Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Disease Indication
      • 10.3.3.2.2. By Therapy

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Product Development
• 12.3. Recent Developments

13. Global Maternal Mental Health Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Therapy Mama
  • 14.1.1. Business Overview
  • 14.1.2. Application Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Key Personnel
  • 14.1.5. SWOT Analysis
• 14.2. Canopie
• 14.3. Pfizer Inc
• 14.4. Viatris Inc.
• 14.5. GlaxoSmithKline Inc.
• 14.6. Alembic Pharmaceuticals Limited
• 14.7. Mallinckrodt Inc.
• 14.8. Sage Therapeutics, Inc.
• 14.9. Bausch Health Companies Inc.
• 14.10. Magellan Health, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer